Literature DB >> 11553024

Comparison of telemetric and tail-cuff blood pressure monitoring in adrenocorticotrophic hormone-treated rats.

T B Fraser1, S W Turner, G J Mangos, J Ludbrook, J A Whitworth.   

Abstract

1. The aim of the present study was to validate a telemetric blood pressure (BP) monitoring system against tail-cuff blood pressure in both adrenocorticotrophic hormone (ACTH)- and sham-treated rats. In the statistical analyses, we first tested whether there was a detectable effect on systolic blood pressure (SBP) of 10 days treatment with ACTH compared with saline. Second, we compared results of telemetered and tail-cuff measurements and, third, we developed a novel method for estimating the relative power of the two techniques. 2. Twenty-three male Sprague-Dawley rats were randomly divided into two groups: (i) ACTH (100 microg/kg per day, s.c; n = 12) treated; or (ii) sham treated (0.9% saline, s.c; n = 11). Systolic BP was measured by the telemetric system (sampled for 10 s every 2 min) continuously for 4 h (n = 16) or for 30 min (n = 23) and also by the indirect tail-cuff method daily (n = 23). Data were compared within and between groups; ordinary least products (OLP) regression analysis was then performed to test for bias between the two methods. Sample size/power estimations were also performed. 3. Adrenocorticotrophic hormone treatment raised telemetered SBP by 11 mmHg (P < 0.001) compared with 14 mmHg (P < 0.001) using the tail-cuff method. There was no fixed or proportional bias between the two methods of measurement, as shown by regression analysis. Power calculations indicate that a minimum sample size of six gives a power of telemetered to tail-cuff of 0.84/0.86 = 0.98. The power of 4 h versus 30 min BP measurements was 0.99/0.82 = 1.2. 4. Telemetry gave very similar results to the tail-cuff method. Telemetry allows for a longer period of measurement, giving greater power to the study so that fewer animals are needed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553024     DOI: 10.1046/j.1440-1681.2001.03531.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  11 in total

1.  LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.

Authors:  Wanghui Jing; Nosratola D Vaziri; Ane Nunes; Yasunori Suematsu; Ted Farzaneh; Mahyar Khazaeli; Hamid Moradi
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists.

Authors:  Christiné S Rigsby; Ashley E Burch; Safia Ogbi; David M Pollock; Anne M Dorrance
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-08-01       Impact factor: 3.619

3.  Kinetics and persistence of cardiovascular and locomotor effects of immobilization stress and influence of ACTH treatment.

Authors:  Esther L Sabban; Nina Schilt; Lidia I Serova; Shreeharsha N Masineni; Charles T Stier
Journal:  Neuroendocrinology       Date:  2008-08-13       Impact factor: 4.914

4.  B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension.

Authors:  Sara J Holditch; Claire A Schreiber; Ryan Nini; Jason M Tonne; Kah-Whye Peng; Aron Geurts; Howard J Jacob; John C Burnett; Alessandro Cataliotti; Yasuhiro Ikeda
Journal:  Hypertension       Date:  2015-05-11       Impact factor: 10.190

5.  Nesfatin-1 activates cardiac vagal neurons of nucleus ambiguus and elicits bradycardia in conscious rats.

Authors:  G Cristina Brailoiu; Elena Deliu; Andrei A Tica; Joseph E Rabinowitz; Douglas G Tilley; Khalid Benamar; Walter J Koch; Eugen Brailoiu
Journal:  J Neurochem       Date:  2013-07-19       Impact factor: 5.372

6.  Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.

Authors:  Madhu V Singh; Michael Z Cicha; Sarah Nunez; David K Meyerholz; Mark W Chapleau; François M Abboud
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-22       Impact factor: 4.733

7.  Rodent Thermoregulation: Considerations for Tail-Cuff Blood Pressure Measurements.

Authors:  Krista J Bigiarelli
Journal:  J Am Assoc Lab Anim Sci       Date:  2022-08-10       Impact factor: 1.706

8.  Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.

Authors:  Quaisar Ali; Yonnie Wu; Tahir Hussain
Journal:  Kidney Int       Date:  2013-07-03       Impact factor: 10.612

9.  Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.

Authors:  Quaisar Ali; Isha Dhande; Preethi Samuel; Tahir Hussain
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-08-05       Impact factor: 1.636

10.  Beneficial Effect of Moderate Exercise in Kidney of Rat after Chronic Consumption of Cola Drinks.

Authors:  Gabriel Cao; Julián González; Angélica Müller; Graciela Ottaviano; Giuseppe Ambrosio; Jorge E Toblli; José Milei
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.